Networking Opportunities

Expand your network before, during, and after the 2017 Genitourinary Cancers Symposium. Connect with colleagues onsite or via one of the professional networking portals below.

Tweeting about the 2017 GU Cancers Symposium? Use the official Symposium hashtag #GU17.

Connect with colleagues on Twitter

Follow the #GU17 Featured Voices for expert insights and live updates from the meeting.

View Featured Voices' disclosure information below.


Start a discussion on LinkedIn



 

Share your experience on Facebook


Discover more on YouTube

Featured Voices Disclosures

All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution

Neeraj Agarwal

Research Funding - amgen (Inst); Bayer (Inst); BN ImmunoTherapeutics (Inst); Bristol-Myers Squibb (Inst); Exelixis (Inst); GlaxoSmithKline (Inst); ImClone Systems (Inst); Medivation (Inst); Novartis (Inst); Pfizer (Inst); Rexahn Pharmaceuticals (Inst); Takeda (Inst); TRACON Pharma (Inst)

Toni K. Choueiri

Honoraria - NCCN; UpToDate

Consulting or Advisory Role - Bayer; Bristol-Myers Squibb; Eisai; Foundation Medicine; GlaxoSmithKline; Merck; Novartis; Pfizer; Prometheus; Roche/Genentech

Research Funding - AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Exelixis (Inst); GlaxoSmithKline (Inst); Merck (Inst); Novartis (Inst); Peloton Therapeutics (Inst); Pfizer (Inst); Roche/Genentech (Inst); TRACON Pharma (Inst)

Bishoy Faltas

No Relationships to Disclose

James L. Gulley

Consulting or Advisory Role - TRM Oncology

Sumanta K. Pal

Honoraria - Astellas Pharma; Medivation; Novartis

Consulting or Advisory Role - Aveo; Bristol-Myers Squibb; Exelixis; Genentech; Myriad Pharmaceuticals; Novartis; Pfizer

Research Funding - Medivation

Elizabeth Plimack

Consulting or Advisory Role - Acceleron Pharma; AstraZeneca/MedImmune; Bristol-Myers Squibb ; Genentech/Roche; Lilly; Novartis; Pfizer; Synergene

Research Funding - Acceleron Pharma (Inst); AstraZeneca (Inst); Bristol-Myers Squibb (Inst); GlaxoSmithKline (Inst); Lilly (Inst); Merck (Inst); Pfizer (Inst)

Patents, Royalties, Other Intellectual Property - U.S. Patent No.: 14/588,503, Filed 1/2/2015. (Inst)